Critical care monitoring expert, Cambridge(UK) based Sphere Medical Holding plc, and cardiovascular devices company Sorin Group, have jointly announced today that Sorin Group has placed an order with Sphere Medical for cardiopulmonary bypass monitors and microanalyser consumables (CPB) for delivery in Q4 2012.
Every year approximately 1.1 million patients globally undergo cardiopulmonary bypass surgery. As guidelines become more stringent, there is a resultant growing demand for close monitoring, demand which Sorin hopes it can tap into through its product development relationship with Sphere.
It’s taking a while though: The original development and supply agreement in relation to the CPB product was signed by the parties in 2008. And this order represents the first sale for this product which will be used by Sorin Group in Market Assessment Studies which are scheduled to commence later this year.
CE Marking of the CPB product is anticipated to coincide with the commencement of the Market Assessment Studies. Satisfactory completion of these studies is expected to lead to a European launch by Sorin Group of the CPB product, which is currently scheduled for Q1 2013. The first commercial sales of the CPB product are anticipated to coincide with the European launch.
The CPB product has been developed to enable the continuous blood monitoring of patients undergoing cardiopulmonary bypass surgery, where close monitoring of oxygenation and other blood parameters are critical. Incorporating Sphere Medical’s core microanalyser technology, the CPB product will allow the clinician to track a comprehensive range of critical blood parameters in real time. This close monitoring will give clinicians an excellent assessment of a patient’s status and enable them to respond rapidly to a patient’s changing condition. This real time analysis is expected to contribute to improving clinical outcomes for
cardiac surgery patients.
Stuart Hendry, CEO of Sphere Medical commented: “Achieving our first order from Sorin for our CPB product
is an important milestone for Sphere Medical and demonstrates our ability to successfully partner our
products with global medical device companies. Sphere Medical continues to make encouraging progress in
the commercialisation of our innovative monitoring and diagnostic products and we look forward to making
further announcements as the year progresses.”
Michel Darnaud, President, Cardiopulmonary Business Unit and Intercontinental, Sorin Group commented:
“We are committed to continuing to deliver product and service excellence to support our worldwide leading
position in cardiopulmonary care through the use of innovative technology to improve patient outcome.
Monitoring of the patient and operating environment is an increasingly important area of cardiopulmonary
surgery, and our collaboration with Sphere Medical fits perfectly within these goals”.
Source: Sphere Medical, Sorin Group